Petros Pharmaceuticals, Inc.
PTPI- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001815903
No open-market purchases or sales by Petros Pharmaceuticals, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Petros Pharmaceuticals, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Petros Pharmaceuticals, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Walker Wayne Remell | Director | 881,333 | Jun 8, 2026 | 2 |
| Silverman Joshua | Director | 8,790,450 | Jun 5, 2026 | 2 |
| Bernstein Bruce | Director | 3,762,334 | Jun 5, 2026 | 2 |
| Boctor Fady | See Remarks | 894,986 | Jun 5, 2026 | 2 |
| Arnold Mitchell | See Remarks | 150,000 | Feb 21, 2025 | 0 |
| Bradley Greg | Director | 8,314 | Dec 26, 2023 | 0 |
| Shulman John D | Director, 10% Owner | 5,703,544Indirect | Jan 3, 2022 | 0 |
| JCP III SM Aiv, L.P. | 10% Owner | 5,703,544Indirect | Jan 3, 2022 | 0 |
| Juggernaut Partners III GP, L.P. | 10% Owner | 5,703,544Indirect | Jan 3, 2022 | 0 |
| Juggernaut Partners III GP, Ltd. | 10% Owner | 5,703,544Indirect | Jan 3, 2022 | 0 |
| METP Holdings LLC | 10% Owner | 5,703,544Indirect | Jan 3, 2022 | 0 |
| Metuchen Therapeutics, LLC | 10% Owner | – | Oct 20, 2021 | 0 |
| Gesek Andrew | President, Timm Medical | – | Aug 5, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 3, 2022 (view filing)6:13 AM ET | Dec 22, 2021 | 12 daysLate | Shulman John D and 4 othersDirector, 10% Owner | PPurchaseCommon Stock, par value $0.0001 per share | +145.8K | $3.43 | +$500.0K | +2.6%5.70M after | |
| Jan 3, 2022 (view filing)6:13 AM ET | Dec 22, 2021 | 12 daysLate | Shulman John D and 4 othersDirector, 10% Owner | PPurchase | +109.3K | $0.00 | $0 | –109.3K after | Derivative |
| Nov 30, 2021 (view filing)2:49 PM ET | Nov 29 | 1 day | Shulman John D and 4 othersDirector, 10% Owner | PPurchaseCommon Stock, par value $0.0001 per share | +500.0K | $3.00 | +$1.50M | +9.9%5.56M after | |
| Nov 30, 2021 (view filing)2:49 PM ET | Nov 29 | 1 day | Shulman John D and 4 othersDirector, 10% Owner | PPurchase | +375.0K | $0.00 | $0 | –375.0K after | Derivative |
| Oct 21, 2021 (view filing)8:47 AM ET | Oct 18 | 3 daysLate | Shulman John D and 4 othersDirector, 10% Owner | PPurchaseCommon Stock, par value $0.0001 per share | +1.66M | $1.72 | +$2.85M | +48.9%5.06M after | |
| Oct 21, 2021 (view filing)8:47 AM ET | Oct 18 | 3 daysLate | Shulman John D and 4 othersDirector, 10% Owner | PPurchase | +1.66M | $0.00 | $0 | –1.66M after | Derivative |